| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3211819 | Journal of the American Academy of Dermatology | 2007 | 15 Pages |
Abstract
The widely accepted standard therapy for cutaneous sarcoidosis includes corticosteroids, antimalarials, and methotrexate. However, a better understanding of the basic immunopathogenic properties of sarcoidosis has elucidated a number of steps critical to the persistence and progression of disease that may be vulnerable to treatment by targeted therapy. This article reviews both standard and newer therapeutic options for cutaneous sarcoidosis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Christy Badgwell, Ted Rosen,